FDA 483 - Bio-Rad Medical Diagnostics GmbH - June 14, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Bio-Rad Medical Diagnostics GmbH in Dreieich, Germany, was inspected by the FDA from June 10-14, 2024, and received a Form 483 with five observations. The inspection revealed significant issues including inadequate risk analysis, unvalidated processes, poor control of non-conforming products, deficient corrective and preventive action procedures, and inadequately maintained document control for consumer complaints. These findings indicate a lack of robust quality system controls for medical diagnostic products.
ID · ccd7b9ad-01b9-44d3-993c-6e099206a38a